| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/30/2008 | CN100364527C Composition of vitamin C and arginine and its application |
| 01/30/2008 | CN100364521C Soft capsule composition containing acetaminophen |
| 01/30/2008 | CN100364515C Drug form with different shapes of cores and shells |
| 01/30/2008 | CN100364510C Drop pills of oldenlandia and preparing method |
| 01/30/2008 | CN100364509C Compound drop pills of dahurian rhododendron leaf and preparation method |
| 01/30/2008 | CN100364508C 'Zhichuanling' Drop pills in use for treating disease of bronchus and preparation method |
| 01/30/2008 | CN100364507C Powerful drop pills of loquat in use for relieving cough and eliminating sputum and preparing method |
| 01/30/2008 | CN100364506C Drop pills preparation in use for treating bronchitis and preparation method |
| 01/30/2008 | CN100364498C Oral aerosol for reducing or eliminating snore and its preparation method |
| 01/29/2008 | US7323474 Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase |
| 01/29/2008 | US7323472 Antiarthritic agents; sepsis shock; malaria; antiischemic agents; respiratory system disorders; brain disorders; congestive heart failure |
| 01/29/2008 | US7323465 Alkansulfonamides as endothelin antagonists |
| 01/29/2008 | US7323316 Glycosyltransferase inhibitors |
| 01/29/2008 | US7323311 Methods of obtaining a specific binding member that binds eotaxin |
| 01/29/2008 | US7323174 Modulation of immune response and methods based thereon |
| 01/29/2008 | US7323118 Composition of hypochlorous acid and its applications |
| 01/29/2008 | CA2436540C Pharmaceutical compositions based on anticholinergics and corticosteroids |
| 01/29/2008 | CA2398485C Azalide antibiotic compositions |
| 01/24/2008 | WO2008011081A2 Wsx-1/p28 as a target for anti-inflammatory responses |
| 01/24/2008 | WO2008010765A1 Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity |
| 01/24/2008 | WO2008010335A1 Plant extract having arthritis-preventive effect |
| 01/24/2008 | WO2008009935A1 Pharmaceutical compositions and their use |
| 01/24/2008 | WO2008009151A1 Tannin-free extract of rhodiola rosea l |
| 01/24/2008 | WO2007137080A3 Compounds and compositions as channel activating protease inhibitors |
| 01/24/2008 | WO2003101437A3 Method of treating asthma using fexofenadine |
| 01/24/2008 | US20080022422 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/24/2008 | US20080021244 Levalbuterol hydrochloride Polymorph A |
| 01/24/2008 | US20080021087 Carbamoylamino-substituted 2,3-dihydro-benzofurans, indoles and benzothiophenes, e.g., (+)-N-((3R)-3-(4-isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide; cerebrovascular disorders |
| 01/24/2008 | US20080021080 4-(3-{[4-(4-Ethyl-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phenyl]thio}phenyl)tetrahydro-2H-pyran-4-carboxamide (Compound No. 1); bronchial asthma, chronic obstructive pulmonary disorder, arthritis, type I diabetes, multiple sclerosis, allograft rejection, psoriasis, inflammatory bowel disease |
| 01/24/2008 | US20080021060 Quinuclidine carbamate derivatives and their use as M3 antagonists |
| 01/24/2008 | US20080021048 such as 8-(2-Fluorophenylamino)-2-(4-methoxyphenylamino)-9-(trans-4-(methylamino)cyclohexyl)-9H-purine, used for for inhibiting neutrophil accumulation in bronchoalveolar lavage fluid |
| 01/24/2008 | US20080021031 Selenophene compounds |
| 01/24/2008 | US20080021029 Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors |
| 01/24/2008 | US20080021025 Inhibitors of cathepsin s |
| 01/24/2008 | US20080021019 immunodeficiencies, cancers, cardiovascular diseases, endocrine disorders, Parkinson's disease, metabolic diseases, tumorigenesis, Alzheimer's disease, heart disease, diabetes, neurodegeneration, inflammation, kidney disease, atherosclerosis and airway disease; substituted pyrazine compounds |
| 01/24/2008 | US20080020983 Peptides with antioxidant and antimicrobial properties |
| 01/24/2008 | US20080020969 36 Human Secreted Proteins |
| 01/24/2008 | US20080020063 Anti-angiogenic compositions and methods of use |
| 01/24/2008 | US20080020055 Phenylephrine Pharmaceutical Formulations and Compositions for Colonic Absorption |
| 01/24/2008 | US20080020048 Treatment of Respiratory Disease |
| 01/24/2008 | US20080020031 Methods and compositions for altering mucus secretion |
| 01/24/2008 | US20080020003 Methods for the delivery of a beta2 agonist to induce bronchodilation and formulations for use in the same |
| 01/24/2008 | US20080019978 nicotinic receptor agonist useful for treating metabolic syndrome, dyslipidemia, cardiovascular diseases, disorders of the peripheral and central nervous system, hematological diseases, cancer, inflammation, respiratory diseases, gastrointestinal diseases, diabetes, and non-alcoholic fatty liver diseases |
| 01/24/2008 | US20080019926 Lung Surfactant Supplements |
| 01/24/2008 | CA2659662A1 Concentrated methotrexate solutions |
| 01/24/2008 | CA2658633A1 Chiral compounds substituted with phosphonic acid ester functions or phosphonic acid functions |
| 01/24/2008 | CA2657639A1 Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity |
| 01/23/2008 | EP1880735A2 Vaccine |
| 01/23/2008 | EP1880213A2 Silver/water, silver gels and silver-based compositions; and methods for making and using the same |
| 01/23/2008 | EP1879888A2 Crystalline forms of tiotropium bromide |
| 01/23/2008 | EP1879884A1 Azole-based phosphodiesterase inhibitors |
| 01/23/2008 | EP1879620A2 Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist |
| 01/23/2008 | EP1879571A1 Combination of medicaments to be inhaled, containing a betamimetic agent and a steroid in addition to an anticholinergic agent |
| 01/23/2008 | EP1673086B1 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors |
| 01/23/2008 | EP1633714B1 2-amino-pyridine derivatives as beta-2 adrenoreceptor agonists |
| 01/23/2008 | EP1610787B1 Synergistic combination comprising roflumilast and an anticholinergic agent selected from tiotropium salts for the treatment of respiratory diseases |
| 01/23/2008 | EP1581224B1 Tiotropium-containing medicament combinations used for inhaling |
| 01/23/2008 | EP1532144B1 quinuclidine derivatives and their use |
| 01/23/2008 | EP1501801B1 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases |
| 01/23/2008 | EP1490366B1 alkoxypyridine-derivatives |
| 01/23/2008 | EP1366175B1 Multifunctional protease inhibitors and their use in treatment of disease |
| 01/23/2008 | EP1339687B1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 01/23/2008 | EP1330451B1 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 01/23/2008 | EP1272514B1 Dna encoding human vanilloid receptor vr3 |
| 01/23/2008 | EP1240332B1 Streptococcus pyogenes virulence genes and proteins and their use |
| 01/23/2008 | EP1220925B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/23/2008 | EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/23/2008 | EP1140998B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/23/2008 | EP1135498B1 Antibody variants with higher binding affinity compared to parent antibodies |
| 01/23/2008 | CN101111488A Novel compounds |
| 01/23/2008 | CN101111243A Classes of compounds that interact with integrins |
| 01/23/2008 | CN101111235A Methods of using and compositions comprising pde4 modulators for treatment, prevention and management airway inflammation |
| 01/23/2008 | CN101108878A Glp-1 analogues |
| 01/23/2008 | CN101108809A 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists |
| 01/23/2008 | CN101108249A Triple killed vaccine for fowl and method of preparing the same |
| 01/23/2008 | CN101108248A Method of preparing newcastle disease, infectiousness bronchitis bigeminy killed vaccine |
| 01/23/2008 | CN101108233A Cough sweets with obvious curative effect |
| 01/23/2008 | CN101108228A Pharmaceutical composition and method of preparing the same |
| 01/23/2008 | CN101108206A Method of preparing cortex mori radicis extractive with glycosidase restraint function |
| 01/23/2008 | CN101108193A Water-solubility rutoside and method of manufacturing the same and oral preparation |
| 01/23/2008 | CN101108166A Quantitative nano aerosol and method of manufacturing the same |
| 01/23/2008 | CN101108164A Bcg polyoses nucleic acid intralipid and its cryochem formulated product and use thereof |
| 01/23/2008 | CN101108018A Poria coco ginger beverage |
| 01/23/2008 | CN100363363C Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/23/2008 | CN100363346C Small molecular inhibiting agent for coronavirus main proteinase, its preparation method and uses |
| 01/23/2008 | CN100363056C Medicine for treating upper respiratory tract infection |
| 01/23/2008 | CN100363020C Throat powder formula for treating throat and oral diseases |
| 01/23/2008 | CN100362994C Preparation for treating allergic rhinitis and asthma |
| 01/23/2008 | CN100362990C Fibrauretine-amino acid fluid for transfusion and its production process |
| 01/23/2008 | CN100362986C Dry powder inhalant composition |
| 01/22/2008 | US7321059 2,3-diethoxylated propionic acid derivatives, e.g., 20-(7,10,13,16-tetraoxaheptadec-1-yloxy)-2,5,8,11,18-pentaoxahenicosan-21-oic acid; for use in inhalation therapy with propellants for treating respiratory system disorders |
| 01/22/2008 | US7320994 {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chloro-phenyl)-methanone; anxiety, depression, psychosis, and schizophrenia and other psychotic disorders; neurodegenerative disorders, multiple sclerosis and amyotrophic lateral sclerosis |
| 01/22/2008 | US7320982 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1 |
| 01/22/2008 | US7320964 Modulation of expression of STAT-1 dependent genes |
| 01/22/2008 | US7320804 Orally administering ferrous sulfate for inhibiting dry cough induced by angiotensin-converting enzyme inhibitors |
| 01/22/2008 | US7320789 Antibody inhibitors of GDF-8 and uses thereof |
| 01/22/2008 | CA2392168C Vitamin d analogues |
| 01/22/2008 | CA2333322C Nitric oxide synthase inhibitors |
| 01/22/2008 | CA2283101C Quinoline leukotriene antagonists |
| 01/22/2008 | CA2257133C Human dnase i hyperactive variants |